Top 10 Biopharma Takeover Targets of 2024
Amid expectations for a rise in M&A activity, market watchers are keeping their eyes on biopharma companies that are ripe for the taking.
Amid expectations for a rise in M&A activity, market watchers are keeping their eyes on biopharma companies that are ripe for the taking.
Scientists shocked as “blue-sky” Marsden Fund has half its budget shifted to research focused on helping economy
Study extends lifespan estimate for one whale species and suggests researchers have been underestimating others as well
Greg Gumbel, a longtime sportscaster who called the NFL for CBS for decades and served as the studio’s host during the NCAA Tournament, has died.
Most leading CDMOs are reporting revenue growth, but according to the CEO of one of these companies, near-term challenges include declining drug discovery activity.
World’s leading microchips hub is ramping up drone-making to help allied countries and counter Beijing.
As part of a project to make mathematics machine-readable, mathematicians have discovered an error in an important proof. Thankfully there was a fix, but the…
Hallucinations, a bane of popular A.I. programs, turn out to be a boon for venturesome scientists eager to push back the frontiers of human knowledge.
Michael Kratsios and Lynne Parker would reprise their roles in first Trump administration and work with AI czar
As much as the world has changed over the past 45 years, its leading regions for biotech activity worldwide are the same now as they…
This hour on The Colin McEnroe Show we discuss whether or not we have free will, and what it would mean if we didn’t.